VivoSeq
Explore
Companies
Drugs
Sign In
Report Error
Akkermansia muciniphila
Preclinical
Small molecule
Y
Yu Chen
1
Indications
1
Total Trials
0
Active Trials
0
Competitors
Pipeline
Status by Indication
[3]
[1]
Indication
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Akkermansia Muciniphila
Completed
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Akkermansia Muciniphila
Preclinical
Completed
Clinical
Trials by Indication
[1]
Akkermansia Muciniphila
1 trial
A Clinical Study to Evaluate the Effects of Akkermansia Muciniphila and Berberine on Prediabetes Among Obese Subjects.
Completed
·
Y
Yu Chen
·
N/A
·
NCT05720299
·
110 enrolled
Sources
References
[1]
ClinicalTrials.gov
—
1 trial record for Akkermansia muciniphila. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL
—
Akkermansia muciniphila compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform
—
Drug–disease associations for Akkermansia muciniphila. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR
—
Yu Chen company filings. U.S. Securities and Exchange Commission.
Details
Drug Info
Quick Facts
Modality
Small molecule
[2]
Highest Phase
Preclinical
[1]
Company
Y
Yu Chen
Related News